₹ 48.60
-1.40 (-2.80%)
BSE
O
Oxygenta Pharmaceutical
₹ 48.60
BSE
Oxygenta Pharmaceutical EPS Summary
The latest quarterly EPS of Oxygenta Pharmaceutical as of Q2 Sep 2026 stands at ₹-0.74. This is a 29.82% fall quarter on quarter and 44.36% growth same quarter last year. For the FY2026 the EPS of Oxygenta Pharmaceutical stands at ₹-4.75. This is a 66.08% fall compared with FY2025.
Oxygenta Pharmaceutical EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

